Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pharmacology down under in 2000.

S A Doggrell1

  • 1Doggrell Biomedical Communications, Lynfield, Auckland, New Zealand.

Drug News & Perspectives
|July 25, 2003
PubMed
Summary
This summary is machine-generated.

Pharmacologists and toxicologists met to discuss animal models for drug development. New Australian medicines, including potassium channel blockers and C5a receptor antagonists, were presented for conditions like traumatic brain injury and rheumatoid arthritis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Do interventions by allied health professionals discussing adherence to insulin improve this adherence?

Diabetes research and clinical practice·2014
Same author

Does intervention by an allied health professional discussing adherence to medicines improve this adherence in Type 2 diabetes?

Diabetic medicine : a journal of the British Diabetic Association·2010
Same author

The heart as a target for oestrogens.

Heart, lung & circulation·2005
Same author

Clinical evidence for drug treatments in obesity-associated hypertensive patients--a discussion paper.

Methods and findings in experimental and clinical pharmacology·2005
Same author

Responsiveness, affinity constants and beta 2-adrenoceptor reserves for isoprenaline on portal veins from normo- and pre- and hypertensive rats.

Autonomic & autacoid pharmacology·2003
Same author

Pharmacology down under in 2001.

Drug news & perspectives·2003

Area of Science:

  • Pharmacology and Toxicology
  • Drug Development
  • Medical Research

Background:

  • The annual scientific meeting of pharmacologists and toxicologists in Australia and New Zealand convenes.
  • The meeting features workshops, lectures, symposia, and free communications.
  • This year's meeting focused on advancements in pharmaceutical research and development.

Purpose of the Study:

  • To summarize key discussions and findings from the annual pharmacologists and toxicologists' meeting.
  • To highlight novel therapeutic targets and drug candidates presented.
  • To showcase the application of animal models in developing molecular pharmaceuticals.

Main Methods:

  • Pre-meeting workshops on specialized topics, such as "Animal Models for the Development of Molecular Pharmaceuticals."

Related Experiment Videos

  • Symposia addressing critical health issues like "Models and New Therapies for Traumatic Brain Injury" and "New Targets for Rheumatoid Arthritis."
  • Presentations of free communications detailing ongoing research and novel findings.

    • Main Results:

    • Exploration of animal models for the development of molecular pharmaceuticals.
    • Discussion of therapeutic strategies for traumatic brain injury and rheumatoid arthritis.
    • Unveiling of novel Australian-developed medicines including potassium channel blockers, C5a receptor agonists and antagonists, brain-derived neurotrophic factor mimetics, and AM-36.

    Conclusions:

    • The meeting facilitated knowledge exchange on cutting-edge pharmaceutical research.
    • Advancements in animal modeling are crucial for developing new molecular pharmaceuticals.
    • Australia is actively developing novel therapeutics for significant unmet medical needs.